Literature DB >> 26021762

Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.

T M Nogueira1, R Lirov, E M Caoili, A M Lerario, B S Miller, M C B V Fragoso, N R Dunnick, G D Hammer, T Else.   

Abstract

Incidentally discovered adrenal masses are common and the clinical evaluation and surveillance aims to diagnose hormone excess and malignancy. Adrenocortical cancer (ACC) is a very rare malignancy. This study aims to define the imaging characteristics of adrenal tumors preceding the diagnosis of ACC. Patients with prior (>5 months) adrenal tumors (<6 cm) subsequently diagnosed with ACC were identified in a large registry at a tertiary referral center. Retrospective chart and image review for patient characteristics and initial, interval, and diagnostic imaging characteristics (size, homogeneity, borders, density, growth rate, etc.) was conducted. Twenty patients with a diagnosis of ACC and a prior adrenal tumor were identified among 422 patients with ACC. Of these, 17 patients were initially imaged with CT and 3 with MR. Only 2 of the 20 patients had initial imaging characteristics suggestive of a benign lesion. Of initial tumors, 25% were <2 cm in size. Surveillance led to the diagnosis of ACC within 24 months in 50% of patients. The growth pattern was variable with some lesions showing long-term stability (up to 8 years) in size. In conclusion, antecedent lesions in patients with a diagnosis of ACC are often indeterminate by imaging criteria and can be small. Surveillance over 2 years detected only 50% of ACCs. Current practice and guidelines are insufficient in diagnosing ACCs. Given the rarity of ACC, the increased risk and health care costs of additional evaluation may not be warranted.

Entities:  

Mesh:

Year:  2015        PMID: 26021762     DOI: 10.1007/s12672-015-0225-2

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  13 in total

Review 1.  Imaging of adrenal incidentalomas: current status.

Authors:  N Reed Dunnick; Melvyn Korobkin
Journal:  AJR Am J Roentgenol       Date:  2002-09       Impact factor: 3.959

Review 2.  The clinically inapparent adrenal mass: update in diagnosis and management.

Authors:  Georg Mansmann; Joseph Lau; Ethan Balk; Michael Rothberg; Yukitaka Miyachi; Stefan R Bornstein
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

Review 3.  Computed tomography--an increasing source of radiation exposure.

Authors:  David J Brenner; Eric J Hall
Journal:  N Engl J Med       Date:  2007-11-29       Impact factor: 91.245

4.  Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.

Authors:  S Leboulleux; C Dromain; G Bonniaud; A Aupérin; B Caillou; J Lumbroso; R Sigal; E Baudin; M Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-12-20       Impact factor: 5.958

Review 5.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

6.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.

Authors:  Rebecca Smith-Bindman; Jafi Lipson; Ralph Marcus; Kwang-Pyo Kim; Mahadevappa Mahesh; Robert Gould; Amy Berrington de González; Diana L Miglioretti
Journal:  Arch Intern Med       Date:  2009-12-14

7.  Differentiation of malignant from benign adrenal masses: predictive indices on computed tomography.

Authors:  S Hussain; A Belldegrun; S E Seltzer; J P Richie; R F Gittes; H L Abrams
Journal:  AJR Am J Roentgenol       Date:  1985-01       Impact factor: 3.959

8.  Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.

Authors:  Elaine M Caoili; Melvyn Korobkin; Richard K J Brown; Gavin Mackie; Barry L Shulkin
Journal:  Acad Radiol       Date:  2007-04       Impact factor: 3.173

9.  Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty?

Authors:  Henry S Park; Sanziana A Roman; Julie Ann Sosa
Journal:  Arch Surg       Date:  2009-11

10.  Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.

Authors:  Wiebke Arlt; Michael Biehl; Angela E Taylor; Stefanie Hahner; Rossella Libé; Beverly A Hughes; Petra Schneider; David J Smith; Han Stiekema; Nils Krone; Emilio Porfiri; Giuseppe Opocher; Jerôme Bertherat; Franco Mantero; Bruno Allolio; Massimo Terzolo; Peter Nightingale; Cedric H L Shackleton; Xavier Bertagna; Martin Fassnacht; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

View more
  6 in total

1.  Somatic mutations in adrenocortical carcinoma with primary aldosteronism or hyperreninemic hyperaldosteronism.

Authors:  Isobel C Mouat; Kei Omata; Andrew S McDaniel; Namita G Hattangady; Debnita Talapatra; Andi K Cani; Daniel H Hovelson; Scott A Tomlins; William E Rainey; Gary D Hammer; Thomas J Giordano; Tobias Else
Journal:  Endocr Relat Cancer       Date:  2019-02       Impact factor: 5.678

Review 2.  5th International ACC Symposium: Imaging for Diagnosis and Surveillance of Adrenal Tumors--New Advances and Reviews of Old Concepts.

Authors:  Stefanie Hahner; Elaine Caoili; Tobias Else
Journal:  Horm Cancer       Date:  2015-12-18       Impact factor: 3.869

3.  Small adrenal incidentaloma becoming an aggressive adrenocortical carcinoma in a patient carrying a germline APC variant.

Authors:  Nadia Gagnon; Pascale Boily; Catherine Alguire; Gilles Corbeil; Irina Bancos; Mathieu Latour; Catherine Beauregard; Katia Caceres; Zaki El Haffaf; Fred Saad; Harold J Olney; Isabelle Bourdeau
Journal:  Endocrine       Date:  2020-02-22       Impact factor: 3.633

4.  Recommendations for the management of adrenal incidentalomas: what is pertinent for radiologists?

Authors:  Anju Sahdev
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

5.  Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases.

Authors:  Cheuk-Lik Wong; Chun-Kit Fok; Yuk-Kit Chan; Vicki Ho-Kee Tam; Lai-Ming Fung
Journal:  Case Rep Endocrinol       Date:  2022-09-14

Review 6.  Is Follow-up of Adrenal Incidentalomas Always Mandatory?

Authors:  Giuseppe Reimondo; Alessandra Muller; Elisa Ingargiola; Soraya Puglisi; Massimo Terzolo
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.